Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
- 1 September 2012
- journal article
- research article
- Published by Elsevier BV in Cell
- Vol. 150 (6), 1135-1146
- https://doi.org/10.1016/j.cell.2012.07.033
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education of the People's Republic of China
- Fudan University
- National Institutes of Health (5P50CA093683-09)
This publication has 39 references indexed in Scilit:
- TET Family Proteins and Their Role in Stem Cell Differentiation and TransformationCell Stem Cell, 2011
- Genome-wide Regulation of 5hmC, 5mC, and Gene Expression by Tet1 Hydroxylase in Mouse Embryonic Stem CellsMolecular Cell, 2011
- Mutant IDH1 Confers an in Vivo Growth in a Melanoma Cell Line with BRAF MutationThe American Journal of Pathology, 2011
- The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onsetNature, 2011
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosineNature Biotechnology, 2011
- Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specificationNature, 2010
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-HydroxyglutarateCancer Cell, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Identification of cells initiating human melanomasNature, 2008